Clinical Trials
4
Active:0
Completed:2
Trial Phases
2 Phases
Phase 3:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (75.0%)Phase 3
1 (25.0%)The Efficacy and Safety of At-home Transcutaneous Electrical Nerve Stimulation in Insomnia
Not Applicable
Not yet recruiting
- Conditions
- Insomnia
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- Ybrain Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05546112
The Efficacy and Safety of tDCS in Patients With Mild Dementia
Not Applicable
Recruiting
- Conditions
- Mild Dementia
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Ybrain Inc.
- Target Recruit Count
- 118
- Registration Number
- NCT05495113
- Locations
- 🇰🇷
The Catholic University of Korea at incheon, Incheon, Korea, Republic of
🇰🇷Korea University, Seoul, Korea, Republic of
The Efficacy and Safety of tDCS in Patients With Mild to Moderate Major Depressive Disorder
Not Applicable
Completed
- Conditions
- Depression
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Ybrain Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT04720040
- Locations
- 🇰🇷
YBrain Inc., Seongnam-si, Gyeonggi-do, Korea, Republic of
The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder
Phase 3
Completed
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2016-01-18
- Last Posted Date
- 2017-01-26
- Lead Sponsor
- Ybrain Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT02657980
- Locations
- 🇰🇷
Ybrain, Seoul, Korea, Republic of
News
No news found